Middlefield, CT, United States of America

Douglas Dischino

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 6.7

ph-index = 6

Forward Citations = 108(Granted Patents)


Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Douglas Dischino**

Introduction

Douglas Dischino is a prominent inventor based in Middlefield, CT, with a substantial portfolio of 10 patents. His work primarily revolves around innovative imaging agents and polypeptides, significantly contributing to the fields of diagnostics and molecular imaging.

Latest Patents

Among his latest inventions are two noteworthy patents focused on PD-L1 binding polypeptides for imaging. These patents introduce novel Fn3 domains specifically designed to bind to PD-L1, alongside imaging agents derived from these domains, intended for diagnostic purposes. The inventive approaches showcased in these patents promise advancements in PET imaging techniques.

Career Highlights

Douglas Dischino has made impactful contributions during his tenure at respected firms, including Lantheus Medical Imaging, Inc. and Bristol-Myers Squibb Company. His expertise and innovative mindset have played a pivotal role in the development of cutting-edge medical imaging technologies.

Collaborations

Throughout his career, Dischino has had the opportunity to collaborate with esteemed colleagues, including David S. Casebier and Heike S. Radeke. These partnerships have fostered a creative environment that propels forward-thinking research and development.

Conclusion

Douglas Dischino’s contributions to the field of medical imaging and diagnostics through his innovative patents underline his status as a significant figure in the world of invention. His ongoing work continues to pave the way for advancements that can potentially enhance diagnostic capabilities and improve patient outcomes in medical settings.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…